We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ideagen Plc | LSE:IDEA | London | Ordinary Share | GB00B0CM0C50 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 349.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMIDEA
RNS Number : 5896C
Ideagen PLC
23 January 2018
23 January 2018
Ideagen PLC
("Ideagen" or the "Group")
Unaudited Interim Results for the six months ended 31 October 2017
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces its unaudited interim results for the six months ended 31 October 2017.
Financial Highlights
-- Revenue increased by 43% to GBP17.2 million (2016: GBP12.0 million)
o Underlying organic revenue growth of 13%
o New bookings increased by 78% to GBP10.8m (2016 : GBP6.1m)
-- Recurring revenues increased by 60% to GBP10.8 million (2016 : GBP6.7 million) -- SaaS revenues increased by 122% to GBP3.9m (2016 : GBP1.7m) -- Recurring revenues represent 63% of total revenue (2016: 56%) -- Adjusted diluted EPS** increased by 38% to 1.73p (2016: 1.25p) -- Adjusted EBITDA* increased by 52% to GBP4.7 million (2016: GBP3.1 million) -- Adjusted PBT** increased by 56% to GBP4.1 million (2016: GBP2.6 million)
-- Cash generated by operations of GBP3.7 million (2016: GBP3.0 million) before a payment to HMRC of GBP0.8 million received from option holders in the prior year for taxes on options exercised
-- Net cash of GBP5.9 million (30 April 2017: GBP4.2 million; 31 October 2016: GBP4.8 million) -- 15% increase in interim dividend to 0.078p (2016: 0.068p)
*Before share based payments and exceptional items
**Before share based payments, amortisation of acquisition intangibles and exceptional items
Operational Highlights
-- Robust growth across all GRC product areas -- Acquisitions made in 2016-17 fully integrated and meeting expectations -- Strong momentum in sales in the USA, Europe and Asia-Pacific Regions -- 112 new logo customer wins - 70% outside of the UK -- Further progress within cloud business
o 66 new logo SaaS customer wins
o Wins include Boston Scientific, Dun and Bradstreet, Roche and RATP Group
-- 46 new logo on premise customer wins including Verizon, Hiscox, Siemens and US Navy -- Strong customer retention - 96% maintenance and support contract renewal rate -- Significant new business from the existing customer base including BAE, Danone and BDO -- Expansion of Malaysian and Bulgarian R&D resources
David Hornsby, CEO of Ideagen, commented: "We are delighted to report on another strong performance from the Group across all of our vertical markets and geographies during the first half of the year.
The Group has achieved growth both organically and from the acquisitions made in the previous year as we continue to execute against our proven strategy. We are particularly pleased with the strong growth in our SaaS revenues and our sales execution and momentum in the USA, Europe and Asia-Pacific regions.
Current trading remains robust and in line with management expectations. The Board remain confident in the outlook for this year and beyond
Enquiries:
Ideagen plc 01629 699100 David Hornsby, Chief Executive Graeme Spenceley, Finance Director Joe O'Brien, Investor Relations finnCap Limited 020 7220 0500 Stuart Andrews/Henrik Persson/James Thompson (Nomad) Stephen Norcross (Corporate Broking)
About Ideagen plc
Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).
Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen can provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency
The Group has a customer base of over 3,000 organisations using the Ideagen of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.
For further information please visit www.ideagen.com
CHIEF EXECUTIVE'S REVIEW
Business Review
I am pleased to report on another excellent performance for the six months ended 31 October 2017 combining overall organic revenue growth of 13% together with a full period's contribution from the acquisitions of Logen, Covalent, IPI and Pleasetech which were made in the previous year. Our Governance Risk and Compliance (GRC) business representing over 90% of Group revenue performed strongly with 20% organic growth. The Content and Clinical business declined by 29% driven by our decision to no longer bid for low margin service based contracts within the UK Public Sector.
The Board believes the long term prospects for the Group are positive. The Governance, Risk and Compliance (GRC) market representing over 90% of Group revenue was, according to Gartner, worth $4.4 billion globally in 2016 and is estimated to be growing at 13% per annum. The Group's core expertise is in the development and implementation of software tools that enable customers to identify, assess and prioritise risk and to manage information in line with rigorous regulations. Our customers are increasingly required to take a holistic view of risk management, internal audit and compliance, with many organisations at the beginning of the adoption phase of high value enterprise-wide solutions.
The Group has a clear and proven strategy to grow the business organically whilst continuing to identify and acquire businesses that offer strong synergies in terms of product, customers and geographical reach. The Board believes that the successful execution on that strategy will continue to bring value to our shareholders, employees and customers. The Group remains committed to increasing its revenue and earnings visibility through the transition to a SaaS and subscription based licence model and the development of international markets, particularly the USA and Asia Pacific.
Demand from all of the Group's key GRC verticals continues to be robust, with new customer wins achieved across a range of industries. The Group is focused on several key vertical markets which are primarily Transport, Banking and Finance, Life Sciences, Healthcare and Advanced Manufacturing. Each of our vertical areas has performed well both in terms of winning new logos and expanding the existing customer footprint through 'cross sell' and 'up sell'. This has resulted in organic growth across our GRC business of 20%. New customer wins in the period include Commerzbank, Dun and Bradstreet, Siemens Transmission, Kerry Foods, mBank, Spirit of Texas Bank, Verizon, RATP Group and Hong Kong Express. New contracts from existing customers include BDO, PWC, Danone, Bae Systems and Lockheed Martin.
The Group continues to benefit from a strong and growing base of recurring revenues, which now represent 63% of total revenue (2016: 56%). Most of this growth is in respect of recurring SaaS revenues which represented 22% (2016: 14%) of total revenues.
The Group has increased it's investment to accelerate a number of product development and global sales initiatives in line with our strong organic revenue growth. We view such investment as important to the sustainable long term growth of the business.
Markets and Product Strategy
GRC
We have subject matter expertise and decades of experience in our vertical markets and in our technology domains. These are as follows:
GRC Domains:
Hot Features
Premium
-- Quality Management
-- Safety Management
-- Risk Management
-- Audit Management
-- Performance Management
Vertical markets:
-- Transport
-- Advanced Manufacturing
-- Life Sciences
-- Government
-- Healthcare
-- Financial Services
We develop and sell software products that satisfy our customers' critical needs at the intersection of these domains and markets. Thus, we primarily provide risk based quality and safety management software to the transport, manufacturing, life sciences and healthcare markets and risk based audit and performance software to financial services, accounting firms and the public sector.
Due to the horizontal nature of GRC, the Group can also supply to other vertical markets, for example Oil and Gas and Construction and it is likely that additional key vertical markets will evolve over time.
Clinical Workflow
Ideagen also provides clinical workflow software solutions to the UK NHS where trusts are seeking to modernise and transform processes by digitising medical records. The primary goal of this transformation is to improve patient outcomes and care quality while also generating efficiency savings. The NHS is aiming to implement widespread modernisation and digitisation of working practices. Ideagen clinical workflow and hospital information management solutions have been designed in close collaboration with NHS customers to deliver innovation and improvements in quality, performance and productivity. New business opportunities within the NHS have been limited due to budget constraints which has resulted in a decline in revenues over the past 3 years.
Acquisition Strategy
The Group made 4 acquisitions in the previous year each of which are fully integrated into the Group and are performing well by adding intellectual property, recurring revenues, vertical market consolidation and technical expertise to the Group. They now form part of our enlarged GRC business and now fit into the Group as follows:
-- Covalent, a supplier of risk assurance and performance management software to the Public Sector and Financial Services has now been integrated with Pentana Audit and rebranded as Pentana Performance providing a broader solution for Enterprise Risk Management
-- IPI, a supplier of quality reporting software to the Aerospace and Defence Industry has been rebranded and is now marketed as a module within the Q-Pulse product range
-- Pleasetech's Document Review and Co-authoring software PleaseReview remains a strong brand within the Group. PleaseReview can be sold independently to enhance a prospective customer's existing Information Management capability or as part of a broader Ideagen GRC solution.
-- Logen, a reseller of "Ideagen Pentana" is now Ideagen Bulgaria and providing a platform for the expansion of the Group's Research and Development and Sales capability in Eastern Europe.
The Group continues to be committed to a 'buy and build' strategy and is in discussion with a number of potential acquisition targets which the Board believe would enhance the Group and support our ongoing growth strategy.
Current Trading & Outlook
The market for GRC management solutions remains fragmented and the drivers are long term and highly strategic. Trading continues to remain robust while a healthy pipeline reinforces confidence in our forecasts.
We have been aware of the economic and political conditions in the UK for some time and the Group has responded by developing a strong and growing presence in a number of global markets. Our success in winning new business together with our increasing levels of recurring revenue and repeat business from our 3,000 strong customer base, provides us with confidence in the future prospects of the Group.
David Hornsby
Chief Executive Officer
FINANCIAL REVIEW
Revenue for the 6 months ended 31 October 2017 increased by 43% to GBP17.2 million (2016: GBP12.0 million) which included strong pro-forma organic revenue growth of 13%. This is calculated based on a comparison with pro-forma revenue for 2016 of GBP15.2 million which includes revenues for Covalent, IPI, PleaseTech and Logen as if those businesses had been owned by the Group for the whole of the comparative period.
New sales bookings increased by 78% to GBP10.8 million (2016: GBP6.1 million). For SaaS based contracts, a booking includes 3 years of SaaS subscriptions and associated professional services revenues. For on-premise based contracts, a booking includes a perpetual licence, 1 year of maintenance and associated professional services revenues.
Recurring revenues have grown strongly because of both the continuing focus on our SaaS/Subscription-based products and the acquisitions of businesses with high levels of recurring revenues. In the 6 months to 31 October 2017, SaaS revenues were GBP3.9 million (2016: GBP1.7 million) representing 22% (2016: 14%) of Group revenue. Total recurring revenues increased by 60% to GBP10.8 million (2016: GBP6.7 million) representing 63% (2016: 56%) of overall revenues. Revenues are analysed by revenue stream in note 2.
The group provides software solutions in two areas; GRC and Content and Clinical, although the Group is now almost entirely focused on GRC products after further resources were re-deployed from Content and Clinical to GRC to address the wider and more profitable opportunities available in the GRC market. Revenues from GRC products increased to 91% (2016: 82%) of Group revenue in the 6 months to 31 October 2017 as a result of both the acquisitions of GRC businesses in the prior year and strong pro-forma organic GRC revenue growth of 20% in the period. As a result of the Group's increased concentration of its resources on GRC products, Content and Clinical revenues declined in the period to GBP1.6 million (2016: GBP2.2 million) representing only 9% (2016: 82%) of total Group revenue in the first half. The majority of this decline is due to the Group's decision to no longer bid for contracts for the design and build of web sites for the UK public sector which represented lower margin, service based business for the Group.
Adjusted EBITDA increased by 52% to GBP4.7 million (2016: GBP3.1 million). The adjusted EBITDA margin improved to 27.5% (2016: 25.8%) resulting from the gearing effect of strongly growing revenues while maintaining control of costs. Revenues are seasonally biased towards the second half of the year thereby resulting in higher adjusted EBITDA margins in the second half and for the year as a whole.
The Group has significant intangible assets from the acquisitions it has made. The amortisation of these acquired intangibles of GBP2.9 million (2016: GBP2.0 million) represents the majority of the total depreciation and amortisation charge for the period of GBP3.5 million (2016: GBP2.4 million). The amortisation of development costs amounted to GBP0.5 million (2016: GBP0.4 million). The share-based payment charge of GBP0.4 million (2016: GBP0.5 million) relates to the group's equity-settled share option schemes including the group's Long Term Incentive Plan and the Group's share incentive plan for employees.
The adjusted group tax charge was GBP0.5 million (2016: GBP0.3 million) and is analysed in note 5. This has been adjusted to exclude the deferred taxation credits associated with the amortisation of acquired intangibles and share-based payment charges. The adjusted group tax charge represents 12% (2016: 12%) of adjusted PBT of GBP4.1 million (2016: GBP2.6 million) which is also analysed in note 5. The Group continues to benefit from the availability of R&D taxation credits.
As a result of the above, adjusted diluted earnings per share increased by 38% to 1.73p (2016: 1.25p). Details of the calculation of adjusted earnings per share are provided in note 3.
The Group's financial position has continued to strengthen with net assets increasing to GBP48.0 million (30 April 2017: GBP46.4 million; 31 October 2016: GBP34.7 million). Net current liabilities were reduced to GBP1.6m (30 April 2017: GBP5.2 million) due to the generation of cash which was largely utilised to repay short-term bank borrowings and some trade and other payables. Current liabilities includes GBP11.2 million (30 April 2017: GBP11.6 million) in respect of revenue invoiced on maintenance and support and SaaS contracts which has been deferred to future periods in accordance with the group's accounting policies. This is not a cash liability.
The level of intangible assets decreased to GBP54.1 million (30 April 2017: GBP56.4 million) mainly through the effects of amortisation and the capitalisation of GBP1.1 million (2016: GBP0.93 million) of R&D development costs during the period which represented 6.4% (2016: 7.7%) of total revenues.
Cash generated by operations was GBP3.7 million (2016: GBP3.0 million) before taking into account a payment to HMRC of GBP0.8 million which had been received from option holders in the prior year to cover their payroll taxes on options exercised by them close to the end of the financial year, as previously noted in our 2017 preliminary announcement. This represents 79% (2016: 96%) of adjusted EBITDA and follows a very strong cash generation metric of over 100% for the year to April 2017 and an unusually high metric in the first half of 2016. Cash generation in the Group is slightly biased towards the second half due to the renewal pattern of our recurring revenue contracts. Free cash flow adjusted for the GBP0.8 million payment noted above, amounted to GBP2.0 million (2016: GBP1.8 million) representing 43% (2016: 59%) of adjusted EBITDA. The group ended the period with net cash balances of GBP5.9 million (30 April 2017: GBP4.2m).
Dividend
The Board proposes to increase the interim dividend by 15% to 0.078 pence per share (2016: 0.068 pence per share) payable on 20th March 2018 to shareholders on the register on 2nd March 2018. The corresponding ex-dividend date is 1(st) March 2018.
Graeme Spenceley
Chief Financial Officer
Ideagen plc
Group Statement of Comprehensive Income for the six months ended 31 October 2017
Six months Six months
ended ended
31 October 31 October
2017 2016
GBP'000 GBP'000
Revenue (note 2) 17,167 12,024
Cost of sales (1,654) (1,436)
Gross profit 15,513 10,588
Operating costs (10,799) (7,481)
----------- -----------
Profit from operating activities
before depreciation, amortisation,
share-based payment charges and
exceptional items 4,714 3,107
Depreciation and amortisation (3,523) (2,446)
Share-based payment charges (414) (509)
Costs of acquiring businesses - (176)
----------- -----------
Profit/(loss) from operating activities 777 (24)
Movement in the fair value of contingent
consideration (4) -
Finance costs (19) -
----------- -----------
Profit/(loss) before taxation 754 (24)
Taxation credit (note 4) 92 26
----------- -----------
Profit for the period 846 2
Other comprehensive income
Items that may be subsequently
reclassified to profit or loss:
Exchange differences on translating
foreign operations (101) 380
Corporation tax on exercise of
options 93 76
Total comprehensive income for
the period attributable to the
owners of the parent company 838 458
=========== ===========
Earnings per share (note 3) Pence Pence
Basic 0.44 0.00
Diluted 0.42 0.00
Ideagen plc
Group Statement of Financial Position at 31 October 2017
31 October 30 April 31 October
2017 2017 2016
GBP'000 GBP'000 GBP'000
Assets and liabilities
Non-current assets
Intangible assets 54,149 56,427 36,887
Property, plant and equipment 628 583 445
Deferred income tax assets 1,134 1,348 777
----------- --------- -----------
55,911 58,358 38,109
----------- --------- -----------
Current assets
Inventories 10 10 16
Trade and other receivables 11,008 10,971 8,941
Current income tax recoverable - 27 -
Cash and cash equivalents 5,861 6,205 4,817
----------- --------- -----------
16,879 17,213 13,774
----------- --------- -----------
Current liabilities
Trade and other payables 3,453 5,115 3,154
Contingent consideration
on business combinations 2,000 2,054 -
Current income tax liabilities 145 - 94
Short term borrowings - 2,000 -
Deferred revenue 11,212 11,609 7,686
Deferred consideration
on business combinations 1,640 1,640 1,623
----------- --------- -----------
18,450 22,418 12,557
----------- --------- -----------
Non-current liabilities
Deferred consideration
on business combinations 460 460 -
Deferred income tax liabilities 5,836 6,274 4,587
----------- --------- -----------
6,296 6,734 4,587
----------- --------- -----------
Net assets 48,044 46,419 34,739
=========== ========= ===========
Ideagen plc
Group Statement of Financial Position at 31 October 2017 (continued)
31 October 30 April 31 October
2017 2017 2016
GBP'000 GBP'000 GBP'000
Equity
Issued share capital 2,000 1,981 1,815
Share premium 33,879 33,405 23,766
Merger reserve 1,658 1,658 1,167
Share-based payments reserve 1,225 961 1,138
Retained earnings 9,050 8,081 6,392
Foreign currency translation
reserve 232 333 461
Equity attributable to
owners of the parent 48,044 46,419 34,739
=========== ========= ===========
Ideagen plc
Group Statement of Cash Flows for the six months ended 31 October 2017
Six months Six months
ended 31 ended 31
October October
2017 2016
GBP'000 GBP'000
Cash flows from operating activities
Profit for the period 846 2
Depreciation of property, plant
and equipment 141 107
Amortisation of intangible non-current
assets 3,382 2,339
Business acquisition costs in
profit or loss - 176
Share-based payment charges
in profit or loss 414 509
Movement in fair value of contingent
consideration 4 -
Finance costs recognised in
profit or loss 19 -
Taxation credit recognised in
profit or loss (92) (26)
Decrease in inventories - 17
Increase in trade and other
receivables (139) (108)
(Decrease)/increase in trade
and other payables (1,285) 194
Decrease in deferred revenue (378) (232)
---------- ----------
Cash generated by operations 2,912 2,978
Finance costs paid (19) -
Income tax repaid 11 42
Employer's national insurance
paid on share-based payments (238) -
Business acquisition costs paid (135) (164)
---------- ----------
Net cash generated by operating
activities 2,531 2,856
---------- ----------
Cash flows from investing activities
Net cash outflow on acquisition
of businesses net of cash acquired - (3,657)
Payments of contingent consideration
on business combination (57) -
Payments for development costs (1,104) (932)
Payments for property, plant
and equipment (185) (90)
Net cash used by investing activities (1,346) (4,679)
---------- ----------
Cash flows from financing activities
Repayment of short term borrowings (2,000) -
Proceeds from issue of shares
under share option scheme 471 193
Proceeds from issue of shares
under share incentive plan 22 -
Net cash (used)/generated by
financing activities (1,507) 193
---------- ----------
Net decrease in cash and cash
equivalents during the period (322) (1,630)
Cash and cash equivalents at
the beginning of the period 6,205 6,317
Effect of exchange rate changes
on cash balances held in foreign
currencies (22) 130
Cash and cash equivalents at
the end of the period 5,861 4,817
---------- ----------
Ideagen plc: Group Statement of Changes in Equity for the six months ended 31 October 2017
Share Share Merger Share-based Retained Foreign Total
capital premium reserve payments earnings currency attributable
reserve translation to owners
reserve of the
parent
-------- -------- --------- ----------- --------- ------------ -------------
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1 May 2017 1,981 33,405 1,658 961 8,081 333 46,419
Shares issued under
share option
scheme 14 457 - - - - 471
Shares issued under
share incentive
plan 5 17 - - - - 22
Share-based payments - - - 414 - - 414
Transfer on exercise
of share
options - - - (150) 150 - -
Taxation on
share-based payments
in equity - - - - (120) - (120)
Total transactions
with owners
recognised directly
in equity 19 474 - 264 30 - 787
-------- -------- --------- ----------- --------- ------------ -------------
Profit for the period - - - - 846 - 846
Other comprehensive
income
for the period - - - - 93 (101) (8)
-------- -------- --------- ----------- --------- ------------ -------------
Total comprehensive
income
for the period - - - - 939 (101) 838
-------- -------- --------- ----------- --------- ------------ -------------
Balance at 31 October
2017 2,000 33,879 1,658 1,225 9,050 232 48,044
======== ======== ========= =========== ========= ============ =============
Ideagen plc: Group Statement of Changes in Equity for the six months ended 31 October 2016
Share Share Merger Share-based Retained Foreign Total
capital premium reserve payments earnings currency attributable
reserve translation to owners
reserve of the
parent
-------- -------- --------- ----------- --------- ------------ -------------
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1 May 2016 1,790 23,598 1,167 1,482 5,565 81 33,683
Shares issued under
share option
scheme 25 168 - - - - 193
Share-based payments - - - 403 - - 403
Transfer on exercise
of share
options - - - (747) 747 - -
Taxation on
share-based payments
in equity - - - - 2 - 2
Total transactions
with owners
recognised directly
in equity 25 168 - (344) 749 - 598
-------- -------- --------- ----------- --------- ------------ -------------
Profit for the period - - - - 2 - 2
Other comprehensive
income
for the period - - - - 76 380 456
-------- -------- --------- ----------- --------- ------------ -------------
Total comprehensive
income
for the period - - - - 78 380 458
-------- -------- --------- ----------- --------- ------------ -------------
Balance at 31 October
2016 1,815 23,766 1,167 1,138 6,392 461 34,739
======== ======== ========= =========== ========= ============ =============
Ideagen plc: Group Statement of Changes in Equity for the year ended 30 April 2017
Share Share Merger Share-based Retained Foreign Total
capital premium reserve payments earnings currency attributable
reserve translation to owners
reserve of the
parent
-------- -------- -------- ----------- --------- ------------ -------------
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1 May 2016 1,790 23,598 1,167 1,482 5,565 81 33,683
Share placing 133 9,867 - - - - 10,000
Share placing issue
costs - (335) - - - - (335)
Shares issued on
acquisition
of business 9 - 491 - - - 500
Shares issued under
share option
scheme 49 275 - - - - 324
Share-based payments - - - 858 - - 858
Transfer on exercise of
share
options - - - (1,379) 1,379 - -
Taxation on share-based
payments
in equity - - - - 475 - 475
Equity dividends paid - - - - (346) - (346)
-------- -------- -------- ----------- --------- ------------ -------------
Total transactions with
owners
recognised directly in
equity 191 9,807 491 (521) 1,508 - 11,476
-------- -------- -------- ----------- --------- ------------ -------------
Profit for the period - - - - 731 - 731
Other comprehensive
income
for the period - - - - 277 252 529
-------- -------- -------- ----------- --------- ------------ -------------
Total comprehensive
income
for the period - - - - 1,008 252 1,260
-------- -------- -------- ----------- --------- ------------ -------------
Balance at 30 April
2017 1,981 33,405 1,658 961 8,081 333 46,419
======== ======== ======== =========== ========= ============ =============
Ideagen plc
Notes to the interim financial information
1 Basis of information
The interim financial information for the 6 months ended 31 October 2017 and the six months ended 31 October 2016 included in this announcement is unaudited. The financial information for the year ended 30 April 2017 included in this announcement does not constitute the annual report and accounts of the Company for the year ended 30 April 2017 within the meaning of section 434 of the Companies Act 2006. The audited annual report and financial statements of the Company for the year ended 30 April 2017 has been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain any statement under section 498 (2) or (3) of the Companies Act 2006 and did not include references to any matters to which the auditor drew attention by way of emphasis. Consistent accounting policies have been applied in the preparation of this information.
2 Revenue
An analysis of the Group's revenue is given below.
31 October 31 October
2017 2016
GBP'000 GBP'000
Recurring SaaS/subscription
software revenues 3,854 1,734
Recurring support & maintenance 6,919 5,015
----------- -----------
Total recurring revenues 10,773 6,749
Software - new licence revenues 3,587 2,415
Professional services 2,515 2,682
Other 292 178
Total revenue 17,167 12,024
----------- -----------
3 Earnings per share information
Basic earnings per share is calculated by dividing the profit for the period attributable to the owners of the Company ('Earnings') by the weighted average number of ordinary shares outstanding during the period. Diluted earnings per share is calculated by dividing Earnings by the weighted-average number of ordinary shares outstanding during the period as adjusted for the effect of all potentially dilutive shares, including share options.
In order to better demonstrate the performance of the Company, adjusted earnings per share calculations have also been presented which take into account items typically adjusted for by users of financial statements. The adjusted earnings and earnings per share information are shown below.
Earnings per share information Six months Six months
ended ended
31 October 31 October
2017 2016
GBP'000 GBP'000
Profit for the period (Earnings) 846 2
Adjustments:
Share-based payment charges 414 509
Deferred taxation on share-based
payment charges (40) 54
Costs of acquiring businesses - 176
Movement in fair value of contingent 4 -
consideration
Amortisation of acquired intangibles 2,927 1,973
Deferred taxation on amortisation
of acquired intangibles (556) (393)
------------ ------------
Adjusted earnings 3,595 2,321
Weighted average number of shares 198,459,844 179,705,928
Diluted weighted average number
of shares 208,016,057 186,201,454
Basic earnings per share 0.44 pence 0.00 pence
Diluted earnings per share 0.42 pence 0.00 pence
Basic adjusted earnings per 1.81 pence 1.29 pence
share
Diluted adjusted earnings per 1.73 pence 1.25 pence
share
4 Taxation
Further information on the taxation charge in the Statement of Comprehensive Income is as follows:
Six months Six months
ended ended
31 October 31 October
2017 2016
GBP'000 GBP'000
Income taxation charge 253 145
Deferred tax credit on amortisation
of acquisition intangibles (556) (393)
Deferred tax on share-based payment
charges (40) 54
Deferred tax charge on utilisation
of tax losses 133 48
Deferred tax charge on development
costs 118 120
Total deferred income taxation
credit (345) (171)
Total taxation credit (92) (26)
----------- -----------
5 Adjusted profit before taxation and adjusted taxation charge
6 months 6 months
ended ended
31 October 31 October
2017 2016
GBP'000 GBP'000
Adjusted earnings (note 3) 3,595 2,321
Adjusted taxation charge (below) 504 313
----------- -----------
Adjusted profit before taxation 4,099 2,634
----------- -----------
Taxation in the Statement of
Comprehensive Income (92) (26)
Add back:
Deferred taxation credit on amortisation
of acquisition intangibles (note
4) 556 393
Deferred taxation on share based
payment charges 40 (54)
----------- -----------
Adjusted taxation charge 504 313
----------- -----------
Adjusted taxation charge based
on adjusted profit before taxation 12.3% 11.9%
----------- -----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR BRGDBCUDBGID
(END) Dow Jones Newswires
January 23, 2018 02:00 ET (07:00 GMT)
1 Year Ideagen Chart |
1 Month Ideagen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
